Arteriosclerosis and Thrombosis, Vol 11, 1752-1758, Copyright © 1991 by American Heart Association

ARTICLES

Metabolism and turnover of cell surface-associated heparan sulfate proteoglycan and chondroitin sulfate proteoglycan in normal and cholesterol-enriched macrophages

RT Owens and WD Wagner
Department of Comparative Medicine, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, N.C.

Analysis of sulfur-35-labeled proteoglycans indicated that cholesterol- enriched pigeon peritoneal macrophages synthesized 42% more 35S-labeled proteoglycan when compared with control macrophages during a 24-hour incubation. Proteoglycan turnover was subsequently studied in radiolabeled macrophage cultures after a 1-, 3-, 6-, 12-, or 24-hour chase with fresh media. During the chase, intracellular proteoglycan disappeared rapidly, whereas there was a small accumulation of 35S- labeled proteoglycan in the media that plateaued at about 6 hours and remained relatively constant thereafter. Pericellular heparan sulfate proteoglycan and chondroitin sulfate proteoglycan disappeared throughout the chase and did not appear to accumulate in the media or in the intracellular compartment. The rapid disappearance of intracellular proteoglycans along with the relative lack in metabolism of media proteoglycans indicated that the majority of pericellular proteoglycans were metabolized via an intracellular degradative pathway. Kinetic analysis of pericellular proteoglycans revealed the presence of a single pool of heparan sulfate proteoglycan (half-life [t1/2] = 6.9 hours) and a single pool of chondroitin sulfate proteoglycan (t1/2 = 11.5 hours) in control macrophage cultures. Cholesterol-enriched macrophage cultures also contained a single pool of pericellular heparan sulfate proteoglycan (t1/2 = 7.3 hours) but contained two pools of chondroitin sulfate proteoglycan (t1/2 = 0.8 hour and 25.9 hours).

This article has been cited by other articles:

				F. de Beer, W. L. Hendriks, L. C. van Vark, S. W.A. Kamerling, K. W. van Dijk, M. H. Hofker, A. H.M. Smelt, and L. M. Havekes Binding of ß-VLDL to Heparan Sulfate Proteoglycans Requires Lipoprotein Lipase, Whereas ApoE Only Modulates Binding Affinity Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 633 - 637. [Abstract] [Full Text] [PDF]

				C.-Y. Lin, M. Lucas, and T. Mazzone Endogenous apoE expression modulates HDL3 binding to macrophages J. Lipid Res., February 1, 1998; 39(2): 293 - 301. [Abstract] [Full Text]

				K. J. Williams and I. Tabas The Response-to-Retention Hypothesis of Early Atherogenesis Arterioscler Thromb Vasc Biol, May 1, 1995; 15(5): 551 - 561. [Full Text]

				I. J. Edwards, H. Xu, J. C. Obunike, I. J. Goldberg, and W. D. Wagner Differentiated Macrophages Synthesize a Heparan Sulfate Proteoglycan and an Oversulfated Chondroitin Sulfate Proteoglycan That Bind Lipoprotein Lipase Arterioscler Thromb Vasc Biol, March 1, 1995; 15(3): 400 - 409. [Abstract] [Full Text]